# Omega Interferon Alone or in Combination With Ribavirin in Subjects With Hepatitis C

> **NCT00097045** · PHASE2 · COMPLETED · sponsor: **Intarcia Therapeutics** · enrollment: 90 (—)

## Conditions studied

- Hepatitis C

## Interventions

- **DRUG:** omega interferon
- **DRUG:** Ribavirin

## Key facts

- **NCT ID:** NCT00097045
- **Lead sponsor:** Intarcia Therapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-11
- **Primary completion:** —
- **Final completion:** 2006-12
- **Target enrollment:** 90 (—)
- **Last updated:** 2007-08-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00097045

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00097045, "Omega Interferon Alone or in Combination With Ribavirin in Subjects With Hepatitis C". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT00097045. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*